Clinical Trial Update: Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

ClinicalTrials.gov reports a Phase 1b/2 study of carfilzomib in relapsed solid tumors, multiple myeloma, or lymphoma. The study is completed and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Multiple Myeloma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Renal Cell Carcinoma
• Small Cell Lung Cancer

Drugs mentioned

• Kyprolis (carfilzomib)

Snippet

Sponsor: Amgen | Conditions: Ovarian Cancer, Renal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-12-09